NeuroBo Pharmaceuticals (NRBO) Competitors $1.94 +0.06 (+2.91%) As of 01/17/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NRBO vs. TCBC, FUSB, BYFC, CNCK, FFBW, CULL, SDIG, CPBI, USIO, and NSTSShould you be buying NeuroBo Pharmaceuticals stock or one of its competitors? The main competitors of NeuroBo Pharmaceuticals include TC Bancshares (TCBC), First US Bancshares (FUSB), Broadway Financial (BYFC), Coincheck Group (CNCK), FFBW (FFBW), Cullman Bancorp (CULL), Stronghold Digital Mining (SDIG), Central Plains Bancshares (CPBI), Usio (USIO), and NSTS Bancorp (NSTS). These companies are all part of the "banking" industry. NeuroBo Pharmaceuticals vs. TC Bancshares First US Bancshares Broadway Financial Coincheck Group FFBW Cullman Bancorp Stronghold Digital Mining Central Plains Bancshares Usio NSTS Bancorp NeuroBo Pharmaceuticals (NASDAQ:NRBO) and TC Bancshares (NASDAQ:TCBC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment. Which has more volatility and risk, NRBO or TCBC? NeuroBo Pharmaceuticals has a beta of -0.26, indicating that its stock price is 126% less volatile than the S&P 500. Comparatively, TC Bancshares has a beta of 0.11, indicating that its stock price is 89% less volatile than the S&P 500. Does the media prefer NRBO or TCBC? In the previous week, NeuroBo Pharmaceuticals' average media sentiment score of 0.00 equaled TC Bancshares'average media sentiment score. Company Overall Sentiment NeuroBo Pharmaceuticals Neutral TC Bancshares Neutral Do institutionals & insiders have more ownership in NRBO or TCBC? 1.4% of NeuroBo Pharmaceuticals shares are held by institutional investors. Comparatively, 23.6% of TC Bancshares shares are held by institutional investors. 1.1% of NeuroBo Pharmaceuticals shares are held by company insiders. Comparatively, 9.6% of TC Bancshares shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is NRBO or TCBC more profitable? TC Bancshares' return on equity of 0.00% beat NeuroBo Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets NeuroBo PharmaceuticalsN/A -189.12% -122.31% TC Bancshares N/A N/A N/A Does the MarketBeat Community prefer NRBO or TCBC? NeuroBo Pharmaceuticals received 27 more outperform votes than TC Bancshares when rated by MarketBeat users. Likewise, 75.00% of users gave NeuroBo Pharmaceuticals an outperform vote while only 0.00% of users gave TC Bancshares an outperform vote. CompanyUnderperformOutperformNeuroBo PharmaceuticalsOutperform Votes2775.00% Underperform Votes925.00% TC BancsharesOutperform VotesNo VotesUnderperform Votes1100.00% Do analysts rate NRBO or TCBC? NeuroBo Pharmaceuticals presently has a consensus target price of $10.00, indicating a potential upside of 414.14%. Given NeuroBo Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts plainly believe NeuroBo Pharmaceuticals is more favorable than TC Bancshares.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroBo Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00TC Bancshares 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger valuation and earnings, NRBO or TCBC? TC Bancshares has higher revenue and earnings than NeuroBo Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroBo PharmaceuticalsN/AN/A-$12.47MN/AN/ATC Bancshares$21.97M3.33$270KN/AN/A SummaryTC Bancshares beats NeuroBo Pharmaceuticals on 7 of the 12 factors compared between the two stocks. Get NeuroBo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRBO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRBO vs. The Competition Export to ExcelMetricNeuroBo PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.76M$6.58B$5.39B$9.13BDividend YieldN/A2.96%5.37%4.00%P/E RatioN/A10.0188.8317.53Price / SalesN/A335.611,282.2680.28Price / CashN/A22.6336.6032.90Price / Book1.305.084.964.69Net Income-$12.47M$154.90M$117.89M$224.57M7 Day Performance-3.23%2.59%2.75%3.33%1 Month Performance21.56%1.52%3.63%5.33%1 Year Performance-41.59%5.49%27.27%22.97% NeuroBo Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRBONeuroBo PharmaceuticalsN/A$1.95+2.9%$10.00+414.1%-41.6%$16.76MN/A0.0010TCBCTC BancsharesN/A$16.90+0.3%N/A+24.5%$70.64M$14.76M0.0050FUSBFirst US Bancshares2.929 of 5 stars$12.22-4.7%N/A+31.7%$69.85M$40.03M8.73180Upcoming EarningsPositive NewsGap UpBYFCBroadway Financial0.7544 of 5 stars$7.62+1.6%N/A+28.6%$69.43M$36.39M26.2880Analyst ForecastGap UpCNCKCoincheck GroupN/A$7.20-17.5%N/AN/A$68.30M$306.16B0.00N/AGap UpFFBWFFBWN/A$13.95-0.4%N/AN/A$67.87M$11.90M0.0040CULLCullman BancorpN/A$9.50-0.1%N/AN/A$64.32M$16.54M19.0050SDIGStronghold Digital Mining2.3068 of 5 stars$3.65-4.2%$6.17+68.9%-21.1%$62.94M$79.53M-0.9920CPBICentral Plains Bancshares1.3252 of 5 stars$14.72-0.5%N/A+34.9%$60.81M$1.11M0.0067News CoveragePositive NewsUSIOUsio3.2189 of 5 stars$2.20-14.4%$5.00+127.3%+45.5%$59.69M$81.03M24.44110Positive NewsNSTSNSTS BancorpN/A$11.31-1.7%N/A+23.7%$59.49M$6.26M-12.5740Positive News Related Companies and Tools Related Companies TC Bancshares Alternatives First US Bancshares Alternatives Broadway Financial Alternatives Coincheck Group Alternatives FFBW Alternatives Cullman Bancorp Alternatives Stronghold Digital Mining Alternatives Central Plains Bancshares Alternatives Usio Alternatives NSTS Bancorp Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NRBO) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRBO Stock Alerts